FDA grants RMAT designation to Ocugen’s OCU410 for eye disease
FDA grants RMAT designation to Ocugen’s OCU410 for eye disease
investing_uk7/29/2026
Page 33 of 51
Sort news
Little-known sign of cancer that 'shouldn't be ignored'
It may seem normal, but it could actually be an early warning sign
dailyrecord7/28/2026
Odevixibat Fails to Improve Native Liver Survival in Phase 3 BOLD Trial for Biliary Atresia
Topline data from the largest disease-modification trial in biliary atresia show no benefit over placebo for the primary endpoint, though the established safety profile in approved indications was maintained.
hcplive7/28/2026
RSV Antibody Shot for Newborns Tied to Fewer Serious Bacterial Infections in a 530,000-Infant Study
A French study of nearly 530,000 infants links the RSV shot nirsevimab to fewer invasive pneumococcal hospitalizations. What it does not prove.
medicaldaily7/28/2026
'I'm fortunate I survived a stage 4 diagnosis when so many didn't make it'
Diagnosed with an aggressive form of breast cancer 10 years ago, aged 37, Lynette McHendry has defied the odds to face down the disease.
bbc7/28/2026
Dermatologists Say Exosome Skincare Is 70% Hype and 30% Science. Here Is What the Science Actually Says.
Exosome skincare is trending, but does it actually work?
mercedsunstar7/28/2026
Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win
An experimental drug targeting both GLP-1 and glucagon receptors has curbed heavy drinking in a phase 2 trial, providing hope that the ubiquitous weight loss meds can be effectively harnessed against alcohol use disorder (AUD).
fiercebiotech7/28/2026
New cholesterol treatment could be 'game changer' for Spokane, says MultiCare cardiologist - Tue, 28 Jul 2026 PST
The Food and Drug Administration approved a drug earlier this month that may change how high cholesterol is treated.
spokesman7/28/2026
B
BioMarin and n─Lorem Foundation ink research collaboration to develop potential first─in─disease medicine for newly identified ReNU syndrome
BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company, and n─Lorem Foundation, a nonprofit organization, announced a strategic collaboration and global exclusive
pharmabiz7/28/2026
12 Million Over-the-Counter Eye Drops Recalled Nationwide, FDA Warns
Millions of eye drops from the brand Rohto have been recalled due to a potential lack of sterility. Here's how to identify affected products.
prevention7/28/2026